Skip to content

Quick ratio at other companies

Merck & Co. logo
Merck & Co.MRK
1.1×-0.2×
Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
0.9×0.0×
LQD
Liquidia CorporationLQDA
-0.9×
United Therapeutics logo
United TherapeuticsUTHR
4.5×-0.7×

Other financials

Income statement

See full
Operating income-$14.9M-30.0%
Net income-$13.2M-27.6%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$19.4M+0.2%
Total debt$682.0K-28.7%
Total equity$172.1M+73.1%
Total assets$179.6M+67.8%

Cash flow

See full
Operating cash flow-$16.7M-23.8%
CapEx$102.0K
Free cash flow-$16.8M

Valuation

See full
Market cap$2.47B+152%
Enterprise value$2.45B+157%

Returns & leverage

See full
Return on equity-33.6%-9.4pp
Debt / equity0.0×
Current ratio24.8×+9.4×

Where this comes from

Calculated from Trevi Therapeutics, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trevi Therapeutics, Inc.'s quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trevi Therapeutics, Inc.'s quick ratio?
Trevi Therapeutics, Inc. (TRVI) reported quick ratio of 24.8× in Q1 2026.
How has Trevi Therapeutics, Inc.'s quick ratio changed year-over-year?
Trevi Therapeutics, Inc.'s quick ratio increased by 60.9% year-over-year, from 15.4× to 24.8×.
What is the long-term trend for Trevi Therapeutics, Inc.'s quick ratio?
Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s quick ratio has grown at a 18.7% compound annual growth rate (CAGR), from 8.3× to 19.7×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.